NCT00545142

Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness

Multi-center, Single Arm, Open Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of Abilify With Depakote in the 6-week Treatment of Acute Mania in Patients With Bipolar Disorder

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 280 (estimated)
• Sponsor: Korea Otsuka Pharmaceutical Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

To demonstrate the efficacy and safety of co-administration of Abilify(aripiprazole) with Depakote(divalproate) in the acute phase of 6-week treatment of acute mania in patients with bipolar disorder.

Detailed description

Further study details as provided by Korea OIAA

Conditions

• Bipolar Disorder

Interventions

Type	Name	Description
DRUG	Abilify(Aripiprazole)	co-administration of Abilify with Depakote in the 6-week treatment of acute mania in patients with bipolar disorder
DRUG	Depakote(Divalproate)	co-administration of Abilify with Depakote in the 6-week treatment of acute mania in patients with bipolar disorder

Timeline

• Start date: 2007-10-01
• Primary completion: 2010-06-01
• Completion: 2010-06-01
• First posted: 2007-10-17
• Last updated: 2010-06-25

Locations

1 site across 1 country: South Korea